Condition: Diabetes · Sponsor: DexCom, Inc.
"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"
This description comes directly from the study's public registry record.
Stayce Beck, PhD · 858 704 2428 · PTL1000088@dexcom.com
Kathleen Hurst · 858 704 2428 · PTL1000088@dexcom.com
Always discuss trial participation with your own doctor first.
| Institute of Endocrinology Diabetes, Health & Hormones | Stockbridge, Georgia, United States | Recruiting |
| Palm Research Center | Las Vegas, Nevada, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06483945